Every one of those 1 sits in a single category, regulation. Andrew Nixon is most often covered alongside ACIP, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 3.4 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Andrew Nixon
Every one of those 1 sits in a single category, regulation. Andrew Nixon is most often covered alongside ACIP, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 3.4 for the broader beat in this window. Their average consequence score of 8 runs above the beat's 6.2 for that window. Andrew Nixon appears in 1 tracked Legal story from March 17, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 54 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Andrew Nixon. Shared-story counts are live from our verified record — not editorial picks.
A federal judge in Massachusetts has issued a stay against the Trump administration's sweeping changes to the national vaccine schedule, ruling that the Department of Health and Human Services bypassed established scientific and legal procedures. The decision halts Secretary Robert F. Kennedy Jr.’s efforts to reduce recommended immunizations and suspends the activities of a newly reconstituted advisory panel.
